Bio-FD&C Co

Bio-FD&C Co Cash Flow per Share

The Operating Cash Flow per Share of Bio-FD&C Co (251120.KQ) as of Nov 14, 2026 is 853.41 KRW. In the previous year, Operating Cash Flow per Share was 707.88 KRW — a change of 20.56% (higher).

Cash Flow per Share

853.41KRW

YoY

20.56%

Last updated:

Operating Cash Flow per Share of Bio-FD&C Co is 2025 853.41 KRW. Operating Cash Flow per Share of Bio-FD&C Co was 2024 707.88 KRW. It decreases by 20.56% higher compared to the previous year.

The Bio-FD&C Co Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
123.37 KRW
Jan 1, 2019
371.08 KRW
Jan 1, 2020
243.50 KRW
Jan 1, 2021
498.51 KRW
Jan 1, 2022
653.44 KRW
Jan 1, 2023
708.97 KRW
Jan 1, 2024
707.88 KRW
Jan 1, 2025
853.41 KRW
The Bio-FD&C Co Cash Flow per Share history
YEARCash Flow per ShareYoY
853.41KRW+20.56%
707.88KRW-0.15%
708.97KRW+8.50%
653.44KRW+31.08%
498.51KRW+104.73%
243.50KRW-34.38%
371.08KRW+200.79%
123.37KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

Operating Cash Flow per Share of Bio-FD&C Co is 853.41 KRW in 2025.

Operating Cash Flow per Share of Bio-FD&C Co changed from 707.88 KRW to 853.41 KRW, representing a 20.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Bio-FD&C Co

All Key Metrics — Bio-FD&C Co